Trial NCT00684996

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2009-01099
Secondary IDs: CDR0000596555 NCI-2009-01099 S0717 U10CA032102

Last trial update was posted on 2014-05-15

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Bevacizumab Immunoglobulins

MeSH Conditions

Carcinoma Carcinoma, Renal Cell

Other Conditions

Recurrent Renal Cell Cancer Renal Cell Carcinoma Stage III Renal Cell Cancer Stage IV Renal Cell Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID